medigraphic.com
Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán

2019, Número 3

<< Anterior Siguiente >>

Rev Invest Clin 2019; 71 (3)


Real-World Evidence of Dengue Burden on Hospitals in Mexico: Insights From the Automated Subsystem of Hospital Discharges (Saeh) Database

Macías AE, Puentes-Rosas E, Velandia D, Morley D, Coudeville L, Baurin N

Idioma: Ingles.
Referencias bibliográficas: 39
Paginas: 168-177
Archivo PDF: 411.57 Kb.


RESUMEN

Sin resumen.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Ebi KL, Nealon J. Dengue in a changing climate. Environ Res. 2016;151:115-23.

  2. WHO. World Health Organization, Dengue and Severe Dengue- Fact Sheet; 2017. Available from: http://www.who.int/mediacentre/ factsheets/fs117/en/. [Last Accessed 2017 Dec 1] .

  3. Nogueira RM, Miagostovich MP, Schatzmayr HG, et al. Dengue in the state of Rio De Janeiro, Brazil, 1986-1998. Mem Inst Oswaldo Cruz. 1999;94:297-304.

  4. Pan American Health Organization (PAHO)/World Health Organization. PLISA Health Platform for the Americas. Topics, Dengue, Regional. Available from: http://www.paho.org/data/ indexphp/en/mnu-topics/indicadores-dengue-en/dengue-regional- en.html. [Last accessed on 2018 Jun 13].

  5. Sarti E, L’Azou M, Mercado M, et al. A comparative study on active and passive epidemiological surveillance for dengue in five countries of Latin America. Int J Infect Dis. 2016;44:44-9.

  6. Pavía-Ruz N, Rojas DP, Villanueva S, et al. Seroprevalence of dengue antibodies in three urban settings in Yucatan, Mexico. Am J Trop Med Hyg. 2018;98:1202-8.

  7. Amaya-Larios IY, Martínez-Vega RA, Mayer SV, et al. Seroprevalence of neutralizing antibodies against dengue virus in two localities in the state of morelos, Mexico. Am J Trop Med Hyg. 2014;91:1057-65.

  8. Hernández-Gaytán SI, Díaz-Vásquez FJ, Duran-Arenas LG, López Cervantes M, Rothenberg SJ. 20 years spatial-temporal analysis of dengue fever and hemorrhagic fever in Mexico. Arch Med Res. 2017;48:653-62.

  9. Undurraga EA, Betancourt-Cravioto M, Ramos-Castañeda J, et al. Economic and disease burden of dengue in Mexico. PLoS Negl Trop Dis. 2015;9:e0003547.

  10. Raghupathi W, Raghupathi V. Big data analytics in healthcare: promise and potential. Health Inf Sci Syst. 2014;2:3.

  11. Dantés OG, Sesma S, Becerril VM, Knaul FM, Arreola H, Frenk J. Sistema de salud de México. Salud Pública Méx. 2011; 53:S220-32.

  12. Australian Government, Australian Institute of Health and Welfare. Metadata Online Registry. National Healthcare Agreement: PI 18-Selected Potentially Preventable Hospitalisations; 2015. Available from: [Last accessed 2017 Dec 2].

  13. International Statistical Classification of Diseases and Related Health Problems, 10th Revision; 2010. Available from: http:// www.apps.who.int/classifications/icd10/browse/2010/en#/.

  14. ENSANUT. Encuesta Nacional de Salud y Nutrición, Resultados Nacionales 2012. Síntesis Ejecutiva; 2012. Available from: http://www.ensanut.insp.mx/doctos/ENSANUT2012_Sint_ Ejec-24oct.pdf.

  15. Australian Institute of Health and Welfare. National Healthcare Agreement: PI 18-Selected Potentially Preventable Hospitalisations. Canberra: Australian Institute of Health and Welfare; 2017.

  16. MySQL. MySQL Workbench 6.3.6. Available from: https://www. mysql.com/.

  17. KNIME. KNIME 3.4.2. Available from: https://www.knime.com/.

  18. The R Foundation. R: a language and Environment for Statistical Computing. Foundation for Statistical Computing. Vienna, Austria; 2013. Available from: http://www.R-project.org/.

  19. San Martín JL, Brathwaite O, Zambrano B, et al. The epidemiology of dengue in the americas over the last three decades: a worrisome reality. Am J Trop Med Hyg. 2010;82:128-35.

  20. Hurtado-Díaz M, Riojas-Rodríguez H, Rothenberg SJ, Gomez- Dantés H, Cifuentes E. Short communication: impact of climate variability on the incidence of dengue in Mexico. Trop Med Int Health. 2007;12:1327-37.

  21. Richardson V, Sánchez-Uribe E, Esparza-Aguilar M, Esteves-Jaramillo A, Suárez-Idueta L. Contribution of Mexico’s universal immunization program to the fourth millennium development goal. Rev Panam Salud Publica. 2014;35:248-55.

  22. Zubieta-Zavala A, Salinas-Escudero G, Ramírez-Chávez A, et al. Calculation of the average cost per case of dengue fever in Mexico using a micro-costing approach. PLoS Negl Trop Dis. 2016;10:e0004897.

  23. Ladner J, Rodrigues M, Davis B, et al. Societal impact of dengue outbreaks: stakeholder perceptions and related implications. A qualitative study in Brazil, 2015. PLoS Negl Trop Dis. 2017; 11:e0005366.

  24. Drennan K, Hicks P, Hart G. Impact of pandemic (H1N1) 2009 on Australasian critical care units. Crit Care Resusc. 2010; 12:223-9.

  25. Leuenberger D, Hebelamou J, Strahm S, et al. Impact of the ebola epidemic on general and HIV care in macenta, forest guinea, 2014. AIDS. 2015;29:1883-7.

  26. Baurin N, Morley D, Ochiai L, Guergova-Kuras M, Afshar M, Coudeville L. Management of Dengue Hospitalizations in Brazil During and Outside Epidemic Periods: insights from Data Mining. ASTMH 2016 Abstract 212; 2016. Available from: https:// www.astmh.org/ASTMH/media/Documents/ASTMH- 2016-Annual-Meeting-Abstract-Book.pdf. [Last accessed 2017 Dec 2].

  27. Pan American Health Organization/World Health Organization. Dengue: annual Cases Reported of Dengue; 2017. Available from: http://www.paho.org/hq/indexphp?option=com_topics& view=rdmore&cid=6290&Itemid=40734. [Last accessed 2018 Mar 22].

  28. Gaxiola-Robles R, Celis A, Serrano-Pinto V, Orozco-Valerio Mde J, Zenteno-Savín T. Mortality trend by dengue in Mexico 1980 to 2009. Rev Invest Clin. 2012;64:444-51.

  29. Rowe EK, Leo YS, Wong JG, et al. Challenges in dengue fever in the elderly: atypical presentation and risk of severe dengue and hospital-acquired infection [corrected]. PLoS Negl Trop Dis. 2014;8:e2777.

  30. Gonzalez-Gonzalez C, Tysinger B, Goldman DP, Wong R. Projecting diabetes prevalence among Mexicans aged 50 years and older: the future elderly model-mexico (FEM-Mexico). BMJ Open. 2017;7:e017330.

  31. Lum LC, Syed Omar SF, Sri La Sri Ponnampalavanar S, et al. Cohorting dengue patients improves the quality of care and clinical outcome. PLoS Negl Trop Dis. 2015;9:e0003836.

  32. Halstead SB, Lum LC. Assessing the prognosis of dengue-infected patients. F1000 Med Rep. 2009;1:73.

  33. de Silva PK, Jayawardena P, Jayarajah U, et al. Improving clinical outcomes through setting up of a specialised dengue treatment unit. Int J Adv Res (Indore). 2017;5:1152-3.

  34. Sridhar S, Luedtke A, Langevin E, et al. Effect of dengue serostatus on dengue vaccine safety and efficacy. N Engl J Med. 2018; 379:327-40.

  35. World Health Organization. Dengue Vaccine: WHO Position Paper; 2018. Available from: http://www.apps.who.int/iris/ bitstream/handle/10665/274315/WER9336.pdf?ua=1. [Last accessed on 2018 Sep 17].

  36. Shepard DS, Coudeville L, Halasa YA, Zambrano B, Dayan GH. Economic impact of dengue illness in the Americas. Am J Trop Med Hyg. 2011;84:200-7.

  37. Muller DA, Depelsenaire AC, Young PR. Clinical and laboratory diagnosis of dengue virus infection. J Infect Dis. 2017; 215:S89-95.

  38. Dantés HG, Farfán-Ale JA, Sarti E. Epidemiological trends of dengue disease in Mexico (2000-2011): a systematic literature search and analysis. PLoS Negl Trop Dis. 2014;8:e3158.

  39. Palmu AA, Kilpi TM, Rinta-Kokko H, et al. Pneumococcal conjugate vaccine and clinically suspected invasive pneumococcal disease. Pediatrics. 2015;136:e22-7




2020     |     www.medigraphic.com